NCT00232739View on ClinicalTrials.gov

Study of the 2.25mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

November 30, 2004

Study Completion Date

August 31, 2009

Conditions
Coronary Artery Disease
Interventions
DEVICE

CYPHER Sirolimus-eluting Coronary Stent

2.25 Cypher Sirolimus-eluting Coronary Stent

Trial Locations (1)

10021

Lenox Hill Hospital, New York

Sponsors

Lead Sponsor

Cordis Corporation
All Listed Sponsors
lead

Cordis Corporation

INDUSTRY

NCT00232739 - Study of the 2.25mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions | Biotech Hunter | Biotech Hunter